16-8628976-G-C
Position:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_024109.4(METTL22):āc.380G>Cā(p.Arg127Thr) variant causes a missense change. The variant allele was found at a frequency of 0.000141 in 1,614,072 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.00044 ( 2 hom., cov: 32)
Exomes š: 0.00011 ( 0 hom. )
Consequence
METTL22
NM_024109.4 missense
NM_024109.4 missense
Scores
1
11
7
Clinical Significance
Conservation
PhyloP100: 4.85
Genes affected
METTL22 (HGNC:28368): (methyltransferase 22, Kin17 lysine) This gene encodes a member of the non-histone lysine methyltransferases. It interacts with its substrate, Kin17, which is involved in DNA repair and replication and mRNA processing. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.048710674).
BS2
High Homozygotes in GnomAd4 at 2 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
METTL22 | NM_024109.4 | c.380G>C | p.Arg127Thr | missense_variant | 3/11 | ENST00000381920.8 | NP_077014.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
METTL22 | ENST00000381920.8 | c.380G>C | p.Arg127Thr | missense_variant | 3/11 | 5 | NM_024109.4 | ENSP00000371345 | P2 | |
METTL22 | ENST00000163678.11 | c.380G>C | p.Arg127Thr | missense_variant, NMD_transcript_variant | 3/10 | 1 | ENSP00000163678 | |||
METTL22 | ENST00000561758.5 | c.281-69G>C | intron_variant | 5 | ENSP00000457152 | A2 | ||||
METTL22 | ENST00000567295.5 | c.*66G>C | 3_prime_UTR_variant, NMD_transcript_variant | 3/5 | 3 | ENSP00000457913 |
Frequencies
GnomAD3 genomes AF: 0.000440 AC: 67AN: 152196Hom.: 2 Cov.: 32
GnomAD3 genomes
AF:
AC:
67
AN:
152196
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000293 AC: 73AN: 249316Hom.: 0 AF XY: 0.000303 AC XY: 41AN XY: 135310
GnomAD3 exomes
AF:
AC:
73
AN:
249316
Hom.:
AF XY:
AC XY:
41
AN XY:
135310
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000109 AC: 160AN: 1461758Hom.: 0 Cov.: 32 AF XY: 0.000121 AC XY: 88AN XY: 727162
GnomAD4 exome
AF:
AC:
160
AN:
1461758
Hom.:
Cov.:
32
AF XY:
AC XY:
88
AN XY:
727162
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000440 AC: 67AN: 152314Hom.: 2 Cov.: 32 AF XY: 0.000604 AC XY: 45AN XY: 74474
GnomAD4 genome
AF:
AC:
67
AN:
152314
Hom.:
Cov.:
32
AF XY:
AC XY:
45
AN XY:
74474
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
2
ExAC
AF:
AC:
23
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 03, 2021 | The c.380G>C (p.R127T) alteration is located in exon 3 (coding exon 2) of the METTL22 gene. This alteration results from a G to C substitution at nucleotide position 380, causing the arginine (R) at amino acid position 127 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D
M_CAP
Benign
T
MetaRNN
Benign
T
MetaSVM
Uncertain
T
MutationAssessor
Uncertain
M
MutationTaster
Benign
D;D
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D
REVEL
Benign
Sift
Uncertain
D
Sift4G
Uncertain
D
Polyphen
D
Vest4
MVP
MPC
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at